Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Vivakor, Inc. (VIVK) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/24/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
Docs: "Vivakor Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q"
04/26/2023 8-K Quarterly results
01/20/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/10/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/21/2022 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "LAND LEASE"
12/02/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/03/2022 8-K Quarterly results
10/06/2022 8-K Quarterly results
08/05/2022 8-K Quarterly results
07/11/2022 8-K Quarterly results
07/08/2022 8-K Quarterly results
06/22/2022 8-K Quarterly results
06/14/2022 8-K Quarterly results
05/02/2022 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "ARTICLE III PRICE",
"Vivakor Awarded Contract for Sale of Asphalt from its Utah Facility"
03/25/2022 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "SHAREHOLDER LETTER",
"Vivakor Collaborates on Prototyping of its Self-Powered Roadway Sensors"
03/15/2022 8-K Quarterly results
02/17/2022 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "UNDERWRITING AGREEMENT",
"FORM OF REPRESENTATIVE'S WARRANT AGREEMENT",
"ClearThink"
12/20/2021 8-K Quarterly results
05/05/2011 8-K Quarterly results
04/29/2011 8-K Financial Statements and Exhibits
Docs: "Vivakor Announces Termination of Memorandum of Understanding to Merge with Resolution Biomedical. Irvine, CA, April 29, 2011"
04/18/2011 8-K Form 8-K - Current report
01/21/2011 8-K Form 8-K - Current report
10/04/2010 8-K Form 8-K - Current report
04/16/2010 8-K Form 8-K - Current report
04/13/2010 8-K Other Events, Financial Statements and Exhibits
Docs: "EXHIBIT 99.1 PRESS RELEASE"
02/12/2010 8-K Form 8-K - Current report
12/10/2009 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "License Agreement between Vivakor, Inc and Regeneca International, Inc.",
"About Regeneca International, Inc. Regeneca™ International, Inc. was formed to create and commercialize products that help consumers improve their health, battle the signs and symptoms of aging and to assist in "regenerating their lives" through its family of natural, organic and phytochemical infused products. The corporate creed is to regenerate the human genetic environment through ecology-centric science. All Regeneca products must fit the highest standard of conservation and reduced carbon footprint. The products must also work to preserve and promote the user's health at the most elemental level of life; the genetic level. The Company's products and philosophy are designed to reconnect the consumer to the Earth's source of healing properties, but with a symbiotic approach. This..."
12/07/2009 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Nonstatutory Stock Option Agreement, Francis Chen",
"Nonstatutory Stock Option Agreement, Fritz Lin",
"VIVAKOR ANNOUNCES ADDITIONS TO BOARD OF DIRECTORS AND SCIENTIFIC ADVISORY BOARD CORALVILLE, Iowa, December 7, 2009 Vivakor, Inc. today announced the addition of new Board of Directors members, Dr. Francis Chen and Fritz Lin, M.D.. Dr. Francis Chen brings over 20 years of healthcare experience to his role as Board member of Vivakor, having held senior management positions at Becton-Dickinson, Baxter Healthcare and Hygeia Sciences/Tambrands among others. Dr. Chen earned his Ph.D. in immunology from Harvard University, and holds an M.S. and a B.S. in chemistry from Tufts University. Dr. Chen is Co-founder and Chairman of Pacific Advantage International, a marketing and sales support organization that assists U.S. and European information technology companies in establishing sales and distribu..."
11/17/2009 8-K Other Events, Financial Statements and Exhibits
Docs: "Vivakor Inc. Announces Stock Dividend Coralville, IA, Nov 17. 2009 Vivakor, Inc. today announced that its Board of Directors approved a dividend of shares of common stock of HealthAmerica, Inc., a Nevada corporation of which Vivakor owns approximately 84% of the outstanding common stock. Each Vivakor shareholder will be entitled to receive one share of HealthAmerica common stock for each share of Vivakor common stock beneficially owned on the record date. The record date for the distribution is expected to be December 1, 2009, subject to review and approval of FINRA, and the distribution date is expected to be December 9, 2009. After the dividend distribution, Vivakor will continue to own approximately 62% of the outstanding common stock of HealthAmerica. Vivakor shareholders will not be r..."
10/13/2009 8-K Form 8-K - Current report

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy